AbbVie Inc. (ABBV) FY2025 Q1 Statement of Cash Flows
2025-01-01 to 2025-03-31
Statement of Cash Flows
2025-01-01 to 2025-03-31
Swipe to see the full flow
Chart details
AbbVie Inc. cash flow reconciliation, Jan 1, 2025 through Mar 31, 2025
Cash flows for Jan 1, 2025 through Mar 31, 2025. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2024. Ending cash: Mar 31, 2025. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.
- Beginning cash on Dec 31, 2024
- 5,524,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- Operating activities
- 1,635,000,000 US dollars. Net cash provided.
- Net earnings
- 1,289,000,000 US dollars
- Depreciation
- 181,000,000 US dollars
- Amortization of intangible assets
- 1,858,000,000 US dollars
- Deferred income taxes
- negative 28,000,000 US dollars
- Change in fair value of contingent consideration liabilities
- 1,518,000,000 US dollars
- Payment for Contingent Consideration Liability, Operating Activities
- negative 549,000,000 US dollars
- Stock-based compensation
- 410,000,000 US dollars
- Acquired IPR&D and milestones
- 248,000,000 US dollars
- Non-cash litigation reserve adjustments, net of cash payments
- negative 729,000,000 US dollars
- Other, net
- 17,000,000 US dollars
- Accounts receivable
- negative 1,479,000,000 US dollars
- Inventories
- negative 155,000,000 US dollars
- Prepaid expenses and other assets
- negative 628,000,000 US dollars
- Accounts payable and other liabilities
- negative 696,000,000 US dollars
- Income tax assets and liabilities, net
- 378,000,000 US dollars
- Investing activities
- negative 735,000,000 US dollars. Net cash used.
- Payments to Acquire Businesses, Net of Cash Acquired
- negative 204,000,000 US dollars
- Other acquisitions and investments
- negative 334,000,000 US dollars
- Acquisitions of property and equipment
- negative 235,000,000 US dollars
- Purchases of investment securities
- negative 10,000,000 US dollars
- Sales and maturities of investment securities
- 32,000,000 US dollars
- Other, net
- 16,000,000 US dollars
- Financing activities
- negative 1,258,000,000 US dollars. Net cash used.
- Net change in commercial paper borrowings
- 1,593,000,000 US dollars
- Proceeds from issuance of other short-term borrowings
- 0 US dollars
- Repayments of other short-term borrowings
- 0 US dollars
- Proceeds from issuance of long-term debt
- 3,994,000,000 US dollars
- Repayments of long-term debt and finance lease obligations
- negative 3,026,000,000 US dollars
- Payments of Debt Issuance Costs
- negative 20,000,000 US dollars
- Dividends paid
- negative 2,925,000,000 US dollars
- Purchases of treasury stock
- negative 961,000,000 US dollars
- Proceeds from the exercise of stock options
- 56,000,000 US dollars
- Other, net
- 31,000,000 US dollars
- Operating adjustment reconciliation
- 4,610,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- financing gross reconciliation
- 6,932,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- investing gross reconciliation
- 783,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- Exchange-rate effect
- 9,000,000 US dollars
- Ending cash on Mar 31, 2025
- 5,175,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- Cash sources and uses
- 7,168,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- Net cash change
- negative 349,000,000 US dollars. Ending cash minus beginning cash.
- Cash flow / Net income
- 1.27×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
- Operating cash flow
- 1,635,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
- Cash purchases of property, plant and equipment
- 235,000,000 US dollars. These cash purchases are already included in investing activities above.
- Free cash flow
- 1,400,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.
Chart connections
- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $346.00M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 1,635,000,000 US dollars minus 235,000,000 US dollars equals 1,400,000,000 US dollars.
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!